TECON BIOLOGY Co.LTD (SHE:002100)
China · Delayed Price · Currency is CNY 7.99
-0.04 (-0.50%)
Sep 14, 2026, 3:04 PM CST
TECON BIOLOGY Co.LTD Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -621.85 | 210.63 | 605.05 | -1,363 | 280.78 | -702.79 |
Depreciation & Amortization | 1,481 | 826.07 | 888.53 | 802.92 | 713.19 | 704.95 |
Other Amortization | 17.32 | 21.14 | 13.05 | 11.11 | 12.49 | 39.34 |
Loss (Gain) From Sale of Assets | -1.31 | -0.59 | -4.5 | -3.9 | -0.23 | 36.72 |
Asset Writedown & Restructuring Costs | 25.3 | 5.72 | 41.58 | 43.7 | 37.82 | 458.49 |
Loss (Gain) From Sale of Investments | -45.11 | -34.64 | 1.87 | -3.46 | -17.81 | -30.92 |
Provision & Write-off of Bad Debts | -24.74 | - | - | - | - | - |
Other Operating Activities | 199.38 | 291.27 | 179.93 | 583.11 | 264.25 | 213.53 |
Change in Accounts Receivable | -178.85 | 148.49 | -605.88 | 855.47 | -528.52 | 759.92 |
Change in Inventory | -535.68 | -969.27 | 367.9 | 861.26 | -548.38 | 158.82 |
Change in Accounts Payable | -174.45 | -236.86 | 9.48 | -65.21 | 78.85 | -98.63 |
Change in Other Net Operating Assets | 131.54 | 131.54 | -307.66 | 53.2 | 50.36 | - |
Operating Cash Flow | 257.79 | 380.86 | 1,162 | 1,752 | 327.99 | 1,533 |
Operating Cash Flow Growth | -87.16% | -67.22% | -33.68% | 434.11% | -78.60% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -352.24 | -378.95 | -626.46 | -1,001 | -1,430 | -1,752 |
Sale of Property, Plant & Equipment | 3.74 | 4.15 | 6.35 | 0.89 | 27.89 | 3.35 |
Cash Acquisitions | -562.41 | - | - | -359.19 | -31.55 | -37.98 |
Divestitures | - | - | - | - | - | 14.1 |
Investment in Securities | -658.55 | -913.55 | -130 | 580.53 | -656.24 | -6.63 |
Other Investing Activities | 7.33 | 0.9 | 0.09 | 4.11 | 17.58 | 4.3 |
Investing Cash Flow | -1,562 | -1,287 | -750.02 | -775 | -2,072 | -1,775 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Long-Term Debt Issued | - | 5,364 | 6,820 | 4,915 | 4,982 | 5,871 |
Total Debt Issued | 6,792 | 5,364 | 6,820 | 4,915 | 4,982 | 5,871 |
Long-Term Debt Repaid | - | -5,558 | -6,786 | -5,882 | -4,740 | -5,611 |
Lease Payments | -149.68 | -149.68 | -84.34 | - | - | - |
Total Debt Repaid | -5,923 | -5,558 | -6,786 | -5,882 | -4,740 | -5,611 |
Net Debt Issued (Repaid) | 868.44 | -193.94 | 33.7 | -966.46 | 242.3 | 260.23 |
Issuance of Common Stock | - | - | 42.35 | - | - | 2,045 |
Common Dividends Paid | -614.23 | -442.61 | -173.32 | -520.34 | -260.85 | -701.74 |
Other Financing Activities | 381.25 | 0.46 | -33.6 | -18.39 | 1,652 | - |
Financing Cash Flow | 635.46 | -636.1 | -130.87 | -1,505 | 1,634 | 1,604 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -0.05 | -0.05 | - | - | - | - |
Net Cash Flow | -668.93 | -1,543 | 280.98 | -528.37 | -110.82 | 1,361 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | -94.45 | 1.91 | 535.4 | 750.48 | -1,102 | -219.37 |
Free Cash Flow Growth | - | -99.64% | -28.66% | - | - | - |
Free Cash Flow Margin | -0.57% | 0.01% | 3.12% | 3.94% | -6.49% | -1.40% |
Free Cash Flow Per Share | -0.07 | 0.00 | 0.39 | 0.56 | -0.82 | -0.20 |
Levered Free Cash Flow | 2,125 | -202.32 | 156.98 | 1,155 | -1,785 | -89.81 |
Unlevered Free Cash Flow | 2,169 | -102.32 | 268.81 | 1,308 | -1,630 | 39 |
Free Cash Flow After Leases | -244.13 | -147.77 | 451.06 | 750.48 | -1,102 | -219.37 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Income Tax Paid | 172.86 | 159.47 | 191.38 | 110.88 | 214.53 | 121.89 |
Change in Working Capital | -772.61 | -938.75 | -563.64 | 1,682 | -962.5 | 813.64 |